|
What An Amazing Difference A Year Makes!
Remember the H1N1 Pandemic? This time last year, the primary news story was
about the H1N1 pandemic. I promised you that we'd get through this in one piece,
that from my research, it wouldn't be as severe as it was feared to be.
And it wasn't.
The death and devastation that was feared and anticipated, didn't happen. The
2009 H1N1 pandemic was milder than the regular flu season.
The good news is that Vitamin D3deficiency appears to be the reason there is a
seasonal flu outbreak. Scientists have demonstrated a link between its deficiency
and the cold and flu season. It is s probably the primary continues to prove to play
a major role in a wide variety of various functions throughout the body. And other
exciting research studies, as previously reported have found its deficiency is linked
to certain cancers, heart disease, stroke and many more.
Other vitamins do play a role. Vitamin C, according to some physicians, should be
given intravenously to most hospitalized patients.
Here's a very intiguing case of a man, near death due to H1N1 that was treated
successfully, when all else failed, with Vitamin C!
29 September 2009
A 56 year old male was referred to Auckland Hospital ICU on 1 July 2009 with total
respiratory failure, for ECMO external oxygenation. The patient had contracted
H1N1 Swine flu (confirmed by tests) while on holiday overseas, and had developed
what is known as 'white out' pneumonia. This refers to x-rays showing no air space in
the lungs.
After 20 days of life-sustaining ECMO treatment and other critical care, the patient,
who was unconscious by induced coma, had not responded. The ICU team advised
the family of the likely outcome and had prepared them for the possibility of the
patient's death.
Family members approached Centre for Advanced Medicine Limited (CAM) for
advice on the clinical use of intravenous vitamin C for such cases.
At the family's request, information was provided to ICU doctors including ISO
9001:2008 registered protocols, safety data, dosages and access to vials of IV
vitamin C under CAM's license for wholesale medicines.
The ICU team agreed to administer intravenous vitamin C according to the family's
wishes. This decision acknowledged the family's rights, in compliance with the New
Zealand Health and Disability Act, 1997.
The patient received intravenous vitamin C starting on the evening of 21 July,
continuing until 29 July. 25 grams was provided on the first day increasing over the
first three days to 50 grams twice daily which was sustained for a further six days.
By 24 July x-rays indicated increasing lung function and ECMO external oxygenation
was discontinued on 26 July. After several days of assisted ventilation and critical
care for ongoing secondary conditions, the patient was able to commence his
recovery and rehabilitation.
The patient was discharged from hospital on Friday 18 September, and is recovering
at home on the farm.
The decision by the Auckland Hospital ICU team to administer adequate dosages of
IV vitamin C, and their skillful coordination of ICU procedures, were responsible for
the positive medical outcome.
Permission from the patient and his family has been sought by CAM to publish these
details on its website and elsewhere in the interests of accuracy. This permission was
willingly provided and CAM expresses its thanks, admiration and respect.
CAM welcomes opportunities to provide similar professional support for registered
medical practitioners and their patients.
Add Us To Your Address Book. To help ensure that you receive all email messages consistently
in your inbox with images displayed, please add this address to your address book or contacts
Have Any Questions? Don't hesitate to hit the reply button to any of the messages you receive.
Have A Topic Idea? I'd love to hear it! Just reply any time and let me know what topics you'd like
to know more about.
| 